Navigation Links
P&G Voluntarily Recalls DayQuil Cold & Flu 24-Count LiquiCaps
Date:12/18/2009

CINCINNATI, Dec. 18, 2009 /PRNewswire/ -- The Procter & Gamble Company (NYSE: PG) announced today it is voluntarily recalling its Vicks® DayQuil® Cold & Flu 24-Count LiquiCaps Bonus Pack in the United States. Consumers should stop using the recalled product.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091218/CL28681 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035LOGO-a )

P&G said it is taking this action because this product does not contain a child-resistant backing for the blister packs in the box, despite label statements that the product is in child-resistant packaging.

No accidental ingestion by children has been reported with this product, and the medication itself is safe for use when taken as directed. However, this product is not intended for use by children under 12, unless recommended by a physician. The lack of child-resistant packaging means it is possible that a child could gain access to the medicine.

Consumers who purchased this DayQuil® 24-count product with the expectation that it was in child-resistant packaging can call P&G at 1-800-251-3374 for a refund or replacement coupon. Anyone with a question can call P&G at this toll-free number or visit www.vicks.com.

Consumers who wish to continue to use the product should do so as directed, taking extra care to keep it out of the reach of children. This medicine could cause serious health problems or death to a child if accidentally swallowed. This product is not intended for children under 12 without a physician's recommendation.

No other DayQuil® or Vicks® products are affected.

P&G has informed the Consumer Product Safety Commission and U.S. Food and Drug Administration. Both support the company's action.

About Procter & Gamble

Four billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Gain®, Pringles®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, Braun® and Fusion®. The P&G community includes approximately 135,000 employees working in about 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands.

SOURCE Procter & Gamble


'/>"/>
SOURCE Procter & Gamble
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
2. Bob McDonald Outlines Key Long Term Growth Strategies To P&G Shareholders
3. Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels
4. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
5. Christie Cookie Recalls Certain Lots of Peanut Butter Cookie Dough Due to Expanded Recall by Peanut Corporation of America
6. Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
7. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
8. Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
9. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
10. Robbins & Myers To Release First Quarter Fiscal 2010 Financial Results
11. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... 24, 2017  ivWatch LLC today announced the ... Board to enable seamless integration of ivWatch,s groundbreaking ... infusion pumps and other devices. By integrating ivWatch ... to help health care customers deliver a higher ... to IV therapy. "The ivWatch OEM ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/10/2017)... MARLBOROUGH, Mass., May 10, 2017 Hologic, Inc. ... financial results for the fiscal second quarter ended April ... (EPS) of $1.84 increased 666.7% compared to the prior ... business resulted in a significant gain, while non-GAAP diluted ... increased 3.2%, or 3.8% in constant currency terms.  Excluding ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... After raising nearly $30,000 on Kickstarter , about ... available at a discounted crowdfunding price on Indiegogo . , “Along with creating ... wanted to bring a fidget toy to the market that was made of superior ...
(Date:5/26/2017)... ... 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in wisdom ... on insurance options. If a Bay Area patient has to search for a second ... Visiting an in-network provider for a second opinion can ensure a patient receives the ...
(Date:5/26/2017)... ... ... in the Garden of Eden”: retells the stories of three Bible figures in modern terms. ... Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. Born in ... six, they moved to Dayton, Ohio, where Penny graduated high school. At sixteen, she ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern ... the most appropriate instruments for research and understanding the basic principles that were ... will focus on innovations in stereo microscopy for brightfield and fluorescence typically used ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... dental implants in Bayside, NY, who have now spent 10 years as clinical ... New York University (NYU) College of Dentistry. Through the program, private practitioners receive ...
Breaking Medicine News(10 mins):